LE Cell Test for Lupus Diagnosis in Karachi at Dr. Essa Lab

LE Cell Test at Dr. Essa Lab

The LE Cell (Lupus Erythematosus Cell) test is a specialized laboratory immunopathology investigation historically and clinically utilized to assist in the diagnosis and evaluation of Systemic Lupus Erythematosus (SLE) and other autoimmune connective tissue disorders. At Dr. Essa Laboratory & Diagnostic Centre, this test is performed with meticulous attention to detail, utilizing advanced microscopic techniques to identify the characteristic immunological phenomenon known as the LE cell. Systemic Lupus Erythematosus is a chronic, multi-system autoimmune disease characterized by the production of autoantibodies directed against self-antigens, particularly nuclear components. The LE cell phenomenon, first described in 1948, serves as a classic laboratory marker of this autoimmune activity, reflecting the complex interactions between circulating autoantibodies, damaged cellular nuclei, and active phagocytic cells.

How the LE Cell test works is rooted in the fundamental principles of clinical immunology and hematology. When a patient’s blood sample is processed in the laboratory, cell damage is deliberately induced to expose nuclear chromatin. In patients with active SLE, the blood contains circulating antinuclear antibodies, specifically those targeted against deoxyribonucleoprotein (anti-DNP), which is also referred to as the LE factor. These autoantibodies bind to the exposed, damaged cell nuclei, causing them to lose their normal chromatin structure and swell into a homogeneous, amorphous, pale-staining mass known as an LE body or hematoxylin body. Active polymorphonuclear neutrophils (PMNs) or other phagocytic cells present in the blood sample then recognize this antibody-coated nuclear material and engulf it. The resulting cell—a neutrophil containing a large, round, structureless, pink-to-blue inclusion body that displaces the host cell’s nucleus to the periphery—is identified under high-power light microscopy as a classic LE cell.

The anatomical and physiological systems evaluated through this test primarily include the immune system and the vascular and connective tissues of the body. Because SLE can affect virtually any organ system, the presence of these autoantibodies is closely linked to systemic inflammation in the joints, skin, kidneys, heart, lungs, brain, and blood vessels. The diagnostic value of the LE Cell test lies in its ability to demonstrate active autoantibody-mediated phagocytosis in vitro, providing direct visual evidence of the patient’s autoimmune status. While modern rheumatology practice has largely transitioned to highly sensitive and quantitative assays such as Antinuclear Antibody (ANA) testing by Immunofluorescence (IFA) and anti-double-stranded DNA (anti-dsDNA) ELISA, the LE Cell test remains an important diagnostic tool in specific clinical scenarios, comparative studies, and resource-limited settings. It offers valuable historical and clinical context, helping clinicians confirm diagnoses of active SLE, drug-induced lupus, and related autoimmune conditions.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the accuracy and reliability of the LE Cell test results. Patients undergoing this investigation at Dr. Essa Lab should adhere to the following clinical guidelines:

• No Fasting Required: Unlike metabolic or lipid panels, the LE Cell test does not require overnight fasting. Patients may consume food and water normally prior to the blood draw.
• Medication Disclosure: It is critical to inform the healthcare provider and laboratory staff of all medications currently being taken. Certain drugs, such as corticosteroids, immunosuppressants, and anti-inflammatory medications, can suppress the immune response and potentially lead to false-negative results.
• Drug-Induced Lupus Screening: If the test is being performed to investigate suspected drug-induced lupus, patients must provide a complete list of medications, especially drugs known to trigger this condition, such as hydralazine, procainamide, isoniazid, quinidine, and phenytoin.
• Hydration: Adequate hydration is highly recommended before the procedure. Drinking plenty of water makes venipuncture easier by ensuring the veins are well-filled and accessible.
• Stress Reduction: Patients should remain calm and relaxed before the blood draw, as extreme physical or emotional stress can occasionally influence transient hematological parameters.

During the Procedure

The LE Cell test requires a venous blood sample, which is collected and processed using specialized laboratory protocols. The clinical procedure at Dr. Essa Lab involves the following steps:

• Patient Positioning: The patient is comfortably seated in a phlebotomy chair, and the arm is extended and supported on an armrest.
• Site Selection and Cleansing: A skilled phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa (inner elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent specimen contamination or hemolysis.
• Venipuncture: A sterile, single-use needle attached to a syringe or vacuum collection tube system is gently inserted into the vein. A tourniquet is applied briefly to the upper arm to facilitate vein localization but is released as soon as blood flow is established.
• Sample Collection: Approximately 5 to 10 mL of venous blood is collected. For the LE Cell test, the blood is typically collected in a plain tube (without anticoagulants) to allow clotting, or in a heparinized tube, depending on the specific laboratory protocol being utilized.
• In Vitro Incubation: Unlike standard blood tests, the LE Cell test requires active laboratory manipulation. The clotted or defibrinated blood sample is incubated at 37 degrees Celsius for approximately 1 to 2 hours. This incubation period is vital, as it allows the autoantibodies in the serum to react with the nuclei of damaged leukocytes and promotes phagocytosis by active neutrophils.
• Slide Preparation and Staining: Following incubation, the blood clot is fragmented or passed through a fine wire mesh to release the cells. The cellular suspension is centrifuged, and smears are prepared from the buffy coat layer, which contains a high concentration of white blood cells. The smears are air-dried and stained using Wright’s or Giemsa stain.
• Microscopic Evaluation: A qualified clinical pathologist carefully examines the stained smears under high-power light microscopy, scanning multiple fields to identify and document the presence of classic LE cells, free nuclear bodies, or associated hematological abnormalities.

When is an LE Cell Test Performed?

Suspected Systemic Lupus Erythematosus (SLE)

The primary clinical indication for requesting an LE Cell test is the suspected diagnosis of Systemic Lupus Erythematosus. Physicians consider this test when a patient presents with a constellation of classic multi-system symptoms, including a malar (butterfly) rash across the cheeks and bridge of the nose, photosensitivity, unexplained hair loss (alopecia), and recurrent oral ulcers. The test assists the clinical team in confirming the presence of circulating antinuclear factors that drive the systemic inflammatory process, providing essential laboratory evidence to support the clinical diagnosis of SLE.

Evaluation of Inflammatory Polyarthritis

Inflammatory polyarthritis, characterized by symmetrical joint pain, swelling, stiffness, and warmth, is a common manifestation of autoimmune diseases. When a patient presents with persistent joint symptoms affecting the small joints of the hands and feet, clinicians utilize the LE Cell test alongside Rheumatoid Factor (RF) and Anti-Cyclic Citrullinated Peptide (anti-CCP) tests. Identifying LE cells helps differentiate lupus-associated arthritis, which is typically non-erosive, from rheumatoid arthritis and other erosive joint diseases, guiding appropriate therapeutic interventions.

Investigation of Drug-Induced Lupus Erythematosus

Drug-Induced Lupus Erythematosus (DILE) is a syndrome that closely mimics idiopathic SLE, triggered by the long-term administration of certain medications. Patients with DILE often present with arthralgias, myalgias, fever, and pleurisy. When a physician suspects DILE, the LE Cell test is performed to detect the characteristic autoantibodies associated with this drug-mediated response. Identifying these cellular changes, in conjunction with a history of exposure to high-risk medications, helps confirm the diagnosis and supports the clinical decision to discontinue the offending drug.

Differential Diagnosis of Connective Tissue Diseases

Autoimmune connective tissue diseases often present with overlapping clinical features, making accurate diagnosis challenging. Clinicians request the LE Cell test as part of a comprehensive immunological panel when evaluating patients with suspected systemic sclerosis (scleroderma), polymyositis, dermatomyositis, or mixed connective tissue disease (MCTD). The presence or absence of LE cells, interpreted alongside other specific autoantibody profiles, assists pathologists and rheumatologists in establishing a precise differential diagnosis.

Unexplained Systemic Inflammatory Symptoms

Patients presenting with chronic, unexplained constitutional symptoms such as persistent low-grade fever, profound fatigue, unexplained weight loss, and generalized lymphadenopathy often undergo an extensive diagnostic workup. When infectious and oncological etiologies have been ruled out, the LE Cell test is performed to screen for underlying systemic autoimmune activity. Detecting LE cells in these patients points toward an autoimmune inflammatory process, prompting further targeted immunological investigations and specialist rheumatology consultation.

What Does an LE Cell Test Detect?

The microscopic evaluation of an LE Cell preparation can reveal several distinct cellular and immunological findings. A comprehensive analysis of the stained blood smear may detect:

• Classic LE Cells: A mature polymorphonuclear neutrophil containing a large, round, homogeneous, structureless, pale-pink or lavender inclusion body (the engulfed denatured nucleus) that completely fills the cytoplasm and pushes the segmented host nucleus to the periphery of the cell.
• Extracellular Amorphous Material: Free-floating, round, homogeneous masses of denatured nuclear material (hematoxylin bodies) that have not yet been phagocytized by neutrophils.
• Rosette Formation: A cluster of active polymorphonuclear neutrophils surrounding a central mass of free extracellular nuclear material, representing the stage of attraction and attachment prior to actual phagocytosis.
• Tart Cells: A monocyte or histiocyte that has engulfed a damaged nucleus, which, unlike the LE cell, still retains some of its original chromatin structure and details. Distinguishing tart cells from true LE cells is critical, as tart cells are non-specific and can be found in healthy individuals or patients with other diseases.
• Leukopenia: A abnormally low total white blood cell count, which is a common hematological manifestation of active systemic lupus erythematosus.
• Neutrophilia: An increased proportion of neutrophils, which may be observed in response to systemic inflammation or secondary infections.
• Thrombocytopenia: A reduced platelet count, indicating potential autoimmune destruction of platelets, often associated with systemic lupus.
• Hemolytic Anemia: Evidence of red blood cell destruction, characterized by polychromasia, spherocytes, or nucleated red blood cells on the blood smear.
• Atypical Lymphocytes: Activated lymphocytes that may be present in response to ongoing systemic immunological stimulation.
• Phagocytized Erythrocytes: Occasionally, macrophages or neutrophils engulfing red blood cells (erythrophagocytosis) may be observed in cases of severe autoimmune hemolytic anemia.
• Nucleophagocytosis: Non-specific engulfment of degenerated nuclei by various white blood cells, requiring careful differentiation from true antibody-mediated LE cell formation.
• Vacuolated Neutrophils: Neutrophils showing cytoplasmic vacuolation, reflecting active phagocytosis and cellular activation.
• Toxic Granulation: Coarse, dark granules within the cytoplasm of neutrophils, indicating severe systemic inflammation or toxic states.
• Lupus Globulin Activity: Indirect evidence of high globulin levels in the blood, which can cause increased background staining or rouleaux formation of red blood cells.
• Eosinophilia: An elevated eosinophil count, which may occasionally coexist in patients with allergic manifestations or specific drug-induced lupus syndromes.
• Monocytosis: An increased number of circulating monocytes, reflecting chronic inflammatory activity and increased phagocytic demand.
• Platelet Satellitism: An in vitro phenomenon where platelets adhere to the periphery of neutrophils, sometimes observed in autoimmune disorders.
• Degenerated Leukocytes: Increased numbers of fragile, smudged, or degenerated white blood cells resulting from the mechanical trauma applied during sample preparation.
• Fibrin Strands: Presence of microscopic fibrin networks, particularly if the defibrination process was incomplete or if there is active intravascular coagulation.
• Anisocytosis and Poikilocytosis: Variations in red blood cell size and shape, commonly associated with chronic inflammatory anemia or autoimmune hemolysis.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Laboratory & Diagnostic Centre, we understand that timely and accurate diagnostic reports are crucial for effective clinical decision-making and patient peace of mind. The LE Cell test is a highly specialized, manual procedure that requires careful incubation, slide preparation, and detailed microscopic examination by an experienced clinical pathologist. Consequently, the turnaround time for this test is typically within 24 to 48 hours from the time of sample collection.

Once the microscopic evaluation is completed and verified by our consultant pathologist, the official report is immediately uploaded to our secure digital database. Patients and referring physicians can access reports online through the official Dr. Essa Lab website or our dedicated mobile application. Additionally, patients receive an automated SMS notification containing a direct link to download their electronic report as soon as it is ready. Physical copies of the report can also be collected from the main laboratory or any of our conveniently located collection centers across Karachi and other major cities.

LE Cell Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
LE Cell Presence	Absent (No LE cells observed)	Present (Classic LE cells identified, indicating SLE or related autoimmune activity)
Extracellular Nuclear Material	Absent	Present (Free hematoxylin bodies or rosette formations observed)
Tart Cells	Absent to rare	Present (Engulfed nuclei with preserved structure, non-specific finding)
Total White Blood Cell (WBC) Count	Normal range (4,000 – 11,000/mcL)	Leukopenia (commonly seen in active SLE) or Leukocytosis (due to inflammation/infection)
Platelet Count	Normal range (150,000 – 450,000/mcL)	Thrombocytopenia (autoimmune platelet destruction)
Red Blood Cell (RBC) Morphology	Normal normocytic, normochromic RBCs	Anisocytosis, poikilocytosis, spherocytes (indicating autoimmune hemolytic anemia)
Antinuclear Antibody (ANA) Correlation	Negative	Strongly positive (highly correlated with the presence of LE cells)
Rheumatoid Factor (RF) Correlation	Negative	Positive (may be present in rheumatoid arthritis or overlap syndromes)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for LE Cell?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical immunologists, and experienced medical technologists who specialize in identifying complex cellular morphology.
• Patient-Focused Care: We prioritize patient comfort and safety, ensuring a smooth, professional, and compassionate experience during sample collection.
• Quality Diagnostic Services: Dr. Essa Lab adheres to strict internal and external quality control protocols, ensuring high diagnostic accuracy and clinical reliability.
• Professional Reporting: Every LE Cell smear is meticulously reviewed under high-power microscopy, and reports are verified by senior consultant pathologists.
• Modern Diagnostic Approach: We combine classic, time-tested laboratory investigations with modern digital reporting systems for seamless clinical integration.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, hygienic, and comfortable environment for all patients.
• Convenient Location: With an extensive network of branches and collection points across Karachi, patients can easily access our diagnostic services.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built decades of trust by consistently delivering precise, evidence-based diagnostic results to the healthcare community.